DaVita Clinical Research Expands Reach of Services at Central Laboratory
The capabilities of DaVita Clinical Research's (DCR) Central Laboratory services have expanded.
Investments in both equipment and its 47,000-square-foot facility allow for generating a daily test volume of approximately 144,000 tests on 60,000 samples per day. DCR rate of delivery is 99.8 percent.
Each clinical project has a project manager to ensure client-specific requirements are met and communication is maintained. Data systems provide fully compliant order entry and reporting with the ability to use anywhere.
The Central Laboratory has developed green packaging for samples. The green packaging features International Air Transport Association (IATA)-compliant storage-friendly design, aiming to reduce shipping costs.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Phase III PROMINENT Trial Initiated to Evaluate Felzartamab for Primary Membranous Nephropathy
June 30th 2025The global Phase III PROMINENT trial has begun dosing patients to evaluate felzartamab in treating primary membranous nephropathy, a serious autoimmune kidney disorder with no FDA-approved therapies.
